These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 104330)

  • 21. Plasma tricyclic drug levels in amitriptyline-treated depressed patients.
    Robinson DS; Cooper TB; Ravaris CL; Ives JO; Nies A; Bartlett D; Lamborn KR
    Psychopharmacology (Berl); 1979 Jun; 63(3):223-31. PubMed ID: 113807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression.
    Bremner JD
    J Clin Psychiatry; 1995 Nov; 56(11):519-25. PubMed ID: 7592505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A risk-benefit assessment of mirtazapine in the treatment of depression.
    Kasper S; Praschak-Rieder N; Tauscher J; Wolf R
    Drug Saf; 1997 Oct; 17(4):251-64. PubMed ID: 9352961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative trial of L-tryptophan and amitriptyline in depressive illness.
    Herrington RN; Bruce A; Johnstone EC; Lader MH
    Psychol Med; 1976 Nov; 6(4):673-8. PubMed ID: 794897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kynurenine pathway in major depression: evidence of impaired neuroprotection.
    Myint AM; Kim YK; Verkerk R; Scharpé S; Steinbusch H; Leonard B
    J Affect Disord; 2007 Feb; 98(1-2):143-51. PubMed ID: 16952400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tryptophan tolerance and metabolism in endogenous depression.
    Møller SE; Kirk L; Honoré P
    Psychopharmacology (Berl); 1982; 76(1):79-83. PubMed ID: 6805013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amitriptyline and nortriptyline response profiles in unipolar depressed patients.
    Lehmann LS; Bowden CL; Redmond FC; Stanton BC
    Psychopharmacology (Berl); 1982; 77(2):193-7. PubMed ID: 6812139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma level monitoring of tricyclic antidepressant therapy.
    Gram LF
    Clin Pharmacokinet; 1977; 2(4):237-51. PubMed ID: 332426
    [No Abstract]   [Full Text] [Related]  

  • 29. Amitriptyline plasma levels and clinical response in primary depression.
    Kupfer DJ; Hanin I; Spiker DG; Grau T; Coble P
    Clin Pharmacol Ther; 1977 Dec; 22(6):904-11. PubMed ID: 923185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antidepressive effect of amitriptyline treatment with plasma drug levels controlled within three different ranges.
    Burch JE; Ahmed O; Hullin RP; Mindham RH
    Psychopharmacology (Berl); 1988; 94(2):197-205. PubMed ID: 3127845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ongoing episode of major depressive disorder is not associated with elevated plasma levels of kynurenine pathway markers.
    Dahl J; Andreassen OA; Verkerk R; Malt UF; Sandvik L; Brundin L; Ormstad H
    Psychoneuroendocrinology; 2015 Jun; 56():12-22. PubMed ID: 25770856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. L-tryptophan in depression.
    Farkas T; Dunner DL; Fieve RR
    Biol Psychiatry; 1976 Jun; 11(3):295-302. PubMed ID: 779855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood noradrenaline and 5-HT levels in depressed women during amitriptyline or lithium treatment.
    Corona GL; Cucchi ML; Santagostino G; Frattini P; Zerbi F; Fenoglio L; Savoldi F
    Psychopharmacology (Berl); 1982; 77(3):236-41. PubMed ID: 6812145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical application of tricyclic antidepressant pharmacokinetics and plasma levels.
    Amsterdam J; Brunswick D; Mendels J
    Am J Psychiatry; 1980 Jun; 137(6):653-62. PubMed ID: 6990798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response to treatment with antidepressants of patients with severe or moderate nonpsychotic depression and of patients with psychotic depression.
    Kocsis JH; Croughan JL; Katz MM; Butler TP; Secunda S; Bowden CL; Davis JM
    Am J Psychiatry; 1990 May; 147(5):621-4. PubMed ID: 2183635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tricyclic plasma levels in depressed outpatients treated with amitriptyline.
    Rickels K; Weise C; Case G; Hucker H
    Psychopharmacology (Berl); 1983; 80(1):14-8. PubMed ID: 6408663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of mirtazapine treatment on serotonin transporter in blood peripheral lymphocytes of major depression patients.
    Peña S; Baccichet E; Urbina M; Carreira I; Lima L
    Int Immunopharmacol; 2005 Jun; 5(6):1069-76. PubMed ID: 15829422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three double-blind comparative trials of mianserine (ORG GB 94) and amitriptyline in the treatment of depressive illness.
    Jaskari MO; Ahfors UG; Ginman L; Lydekcne K; Tienari P
    Pharmakopsychiatr Neuropsychopharmakol; 1977 Mar; 10(2):101-3. PubMed ID: 360231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guidelines for clinical use in interpreting tricyclic plasma levels.
    Molnar G; Wallace J; Gupta R
    Can J Psychiatry; 1979 Oct; 24(6):532-6. PubMed ID: 487346
    [No Abstract]   [Full Text] [Related]  

  • 40. A comparative double-blind controlled study of trimipramine and amitriptyline in major depression: lack of correlation with 5-hydroxytryptamine reuptake blockade.
    Cournoyer G; de Montigny C; Ouellette J; Langlois R; Elie R; Caille G; le Morvan P
    J Clin Psychopharmacol; 1987 Dec; 7(6):385-93. PubMed ID: 3323262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.